QPS Missouri celebrates its pearl anniversary in 2024. Founded as Bio-Kinetic Applications in 1994 by Dale and Linda Bourg, this clinical research organization (CRO) has played a pivotal role in pharmaceutical advancements and FDA approvals.
Over the years, QPS has grown into a global entity, influencing drug development and contributing to the local economy.
Clinical Research in Springfield, MO
CROs play a vital role in the creation and approval of drugs and devices meant to improve quality of life for people who live with a variety of conditions.
Thirty years ago, Bio-Kinetic became the first of its kind in Springfield, Missouri, with humble beginnings in the basement of one of the facilities. The untapped potential in the area proved to be rewarding, and the company grew until its merger with QPS in 2008.
Milestones and Global Presence
QPS is a powerhouse in clinical research, employing over 2,500 individuals globally. Locally, the Springfield facility boasts a 30,000-square-foot research facility with 240 beds, and its impact on the community is substantial.
With over 100 employees, QPS has become an integral part of the Springfield economy, having put more than $50 million back into the community through stipends paid to participants.
Core Values and Trust
Classic Ozarks values are integral to QPS’ culture. Participants who have been involved in studies for two decades trust the organization, fostering a longstanding relationship.
Brendon Bourg, son of Bio-Kinetic founders Dale and Linda Bourg, assumed leadership in 2016 and emphasizes the importance of these values in building client relationships and sustaining the business.
The Clinical Trial Process
QPS is at the forefront of clinical trials, working directly with healthcare companies globally. The company designs trials for various products, ranging from drugs to devices.
The diverse participant pool challenges stereotypes, debunking the notion that only specific demographics are involved. Participants are paid for their involvement, contributing to the local economy and supporting various causes.
Economic Impact and Ethical Practices
QPS has made significant contributions to the Springfield economy, with stipends exceeding $50 million since its inception.
The company is committed to participant safety and trial validity. Recently, QPS upgraded its clinics, enhancing facilities and incorporating state-of-the-art technology to maintain the highest standards.
Expansion and Innovation
QPS’ growth is evident in its expanded operations, including a clinical laboratory, an updated pharmacy, and a dedicated space for building and shipping clinical trial kits.
The state-of-the-art laboratory enables real-time monitoring of subject safety during trials, adding a new level of efficiency. The upgraded pharmacy and kit production area enhance QPS’ capabilities, positioning it as a comprehensive clinical trial service provider.
Contributions to Drug Development
QPS’ impact on drug development is substantial, having assisted in bringing products like Allegra, Mucinex, and Advil to market. QPS collaborates with pharmaceutical companies worldwide, negotiating various tests’ pricing. The regulatory scrutiny by the FDA ensures the highest standards in the conduct of trials.
Future Outlook and Global Collaboration
Looking ahead, QPS anticipates challenges in the pharmaceutical industry due to ongoing mergers and acquisitions. However, the company’s adaptability, a hallmark of its success, positions it to navigate these changes effectively.
With a close-knit group of dedicated professionals and a global presence, QPS continues to be a trailblazer in the clinical research landscape.
In the years to come, the company aims to match its largest trial with 2,000 participants, demonstrating its capability to handle diverse and impactful studies.
The success of QPS Missouri can be attributed to its ability to seamlessly blend local roots with a global vision. The company’s Springfield campus, housing five independent clinics and a screening and recruitment center, serves as a testament to the enduring strength of Ozarks values and hard work.
With alumni returning to participate in studies and volunteers showcasing unwavering trust, QPS embodies the essence of a close-knit community dedicated to the pursuit of medical breakthroughs.
Kicking off the Pearl Anniversary
As QPS celebrates its 30th anniversary in Springfield, the journey unfolds with a legacy of community impact, ethical practices, and global contributions to healthcare innovation. The company’s expansion and commitment to excellence position it as a key player in shaping the future of clinical research studies.
QPS Missouri’s story is not just a celebration of the past 30 years but a testament to its enduring commitment to advancing medical science for the betterment of communities worldwide.
Those interested in participating in a clinical research study are encouraged to learn about ongoing or upcoming studies. Participation is entirely voluntary and can be withdrawn at any time.